NEU neuren pharmaceuticals limited

Ann: 2022 Annual Report to shareholders, page-4

  1. 1,441 Posts.
    lightbulb Created with Sketch. 382
    a good report to remind us the further upside from here is much bigger:

    The transformation of Neuren is just beginning, and the board is committed to maximizing value for our shareholders by maintaining a robust balance sheet that can facilitate the pursuit of all value adding opportunities to their fullest potential
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
0.000(0.00%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.48 $16.77 $16.28 $3.108M 188.0K

Buyers (Bids)

No. Vol. Price($)
1 105 $16.48
 

Sellers (Offers)

Price($) Vol. No.
$16.54 885 2
View Market Depth
Last trade - 16.13pm 28/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.